PSA kinetics and risk of death from prostate cancer - In search of the holy grail of surrogate end points

被引：4
作者：
Anscher, MS [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 294卷 / 04期
关键词：
D O I：
10.1001/jama.294.4.493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：493 / 494
页数：2
相关论文
共 21 条
[11]   Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations [J].
Lee, WR ;
Hanks, GE ;
Hanlon, A .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :230-238
[12]   Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen [J].
Patel, A ;
Dorey, F ;
Franklin, J ;
deKernion, JB .
JOURNAL OF UROLOGY, 1997, 158 (04) :1441-1445
[13]   Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer [J].
Petrylak, DP ;
Tangen, CM ;
Hussain, MHA ;
Lara, PN,J ;
Jones, JA ;
Taplin, ME ;
Burch, PA ;
Berry, D ;
Moinpour, C ;
Kohli, M ;
Benson, MC ;
Small, EJ ;
Raghavan, D ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1513-1520
[14]   Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of Phase III RTOG 85-31 [J].
Pilepich, MV ;
Winter, K ;
Lawton, CA ;
Krisch, RE ;
Wolkov, HB ;
Movsas, B ;
Hug, EB ;
Asbell, SO ;
Grignon, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05) :1285-1290
[15]   Natural history of progression after PSA elevation following radical prostatectomy [J].
Pound, CR ;
Partin, AW ;
Eisenberger, MA ;
Chan, DW ;
Pearson, JD ;
Walsh, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1591-1597
[16]   Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy [J].
Sandler, HM ;
Dunn, RL ;
McLaughlin, PW ;
Hayman, JA ;
Sullivan, MA ;
Taylor, JMG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03) :629-633
[17]   Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy [J].
Sartor, CI ;
Strawderman, MH ;
Lin, XH ;
Kish, KE ;
McLaughlin, PW ;
Sandler, HM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05) :941-947
[18]  
SCARDINO P, 2004, NATL COMPREHENSIVE C
[19]   Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy [J].
Stephenson, AJ ;
Shariat, SF ;
Zelefsky, MJ ;
Kattan, MW ;
Butler, EB ;
Teh, BS ;
Klein, EA ;
Kupelian, PA ;
Roehrborn, CG ;
Pistenmaa, DA ;
Pacholke, HD ;
Liauw, SL ;
Katz, MS ;
Leibel, SA ;
Scardino, PT ;
Slawin, KM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (11) :1325-1332
[20]   Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer [J].
Tannock, IF ;
de Wit, R ;
Berry, WR ;
Horti, J ;
Pluzanska, A ;
Chi, KN ;
Oudard, S ;
Theodore, C ;
James, ND ;
Turesson, I ;
Rosenthal, MA ;
Eisenberger, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1502-1512
123